Home
Conditions
Tumor Virus Infections

Clinical trial condition

Tumor Virus Infections

Explore clinical trials studying Tumor Virus Infections. Study availability and eligibility vary by location and protocol.

1,486 public trials 253 recruiting studies

Refine in advanced search Browse all conditions

Tumor Virus Infections trial results

Active, Not Recruiting

Clinical Study to Evaluate SIIPL qHPV Vaccine (CERVAVAC®) in Women Living With HIV Aged 15-25 Years

NCT06281119

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +11 more
Locations: Centre For Clinical Research, Kemri Nairobi, Kenya

Partners in Health and Research Development (Phrd) Thika, Kenya

Manhiça Health Research Center - Manhiça Foundation (CISM-FM) Manhiça, Mozambique

Clinical HIV Research Unit (CHRU), Helen Joseph Hospital Johannesburg, South Africa

View Trial Details

Active, Not Recruiting

Optimization of Cervical Cancer Screening Among Women Living With HIV in Latin American Countries

NCT06002126

Conditions: Blood-Borne Infections, Cervical High Grade Squamous Intraepithelial Lesion, Cervix Cancer, +31 more
Locations: University of São Paulo São Paulo, Brazil

National Institute of Public Health, Mexico Cuernavaca, Morelos, Mexico

View Trial Details

Active, Not Recruiting

Cervical Pre-cancer Treatment Failure Among Women Living With HIV in Zimbabwe

NCT07202936

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +23 more
Locations: Women's Health Centre at Newlands Clinic Harare, Zimbabwe

View Trial Details

Active, Not Recruiting

Individualized Treatment Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

NCT02135042

Conditions: Carcinoma, DNA Virus Infections, Epstein-Barr Virus Infection, +22 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

The Kirklin Clinic at Acton Road Birmingham, Alabama, United States

Banner University Medical Center - Tucson Tucson, Arizona, United States

Sutter Cancer Centers Radiation Oncology Services-Auburn Auburn, California, United States

View all 215 locations

View Trial Details

Active, Not Recruiting

Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma

NCT01815749

Conditions: Adult Grade III Lymphomatoid Granulomatosis, Blood Protein Disorders, Burkitt Lymphoma, +64 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, Not Recruiting

Novel Small Molecule EBNA1 Inhibitor, VK 2019, in Patients With Epstein Barr Virus (EBV)-Positive Nasopharyngeal Cancer (NPC) and Other Epstein-Barr Virus (EBV)-Associated Cancers, With Pharmacokinetic and Pharmacodynamic Correlative Studies

NCT04925544

Conditions: Carcinoma, DNA Virus Infections, Epstein-Barr Virus Infections, +19 more
Locations: Stanford University Stanford, California, United States

View Trial Details

Active, Not Recruiting

Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV

NCT04255849

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +13 more
Locations: Universidade de São Paulo São Paulo, Brazil

Instituto Nacional de Salud Pública, Mexico Cuernavaca, Morelos, Mexico

University of Puerto Rico AIDS Clinical Trials Unit San Juan, Purto Rico, Puerto Rico

View Trial Details

Active, Not Recruiting

Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients

NCT03876769

Conditions: B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +19 more
Locations: Children s Hospital of Alabama Birmingham, Alabama, United States

Phoenix Childrens Hospital Phoenix, Arizona, United States

City of Hope National Medical Duarte, California, United States

Childrens Hospital Los Angeles Los Angeles, California, United States

View all 43 locations

View Trial Details

Active, Not Recruiting

Post-treatment Surveillance in HPV+ Oropharyngeal SCC

NCT04965792

Conditions: Carcinoma, Carcinoma, Squamous Cell, Communicable Diseases, +20 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Active, Not Recruiting

In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors

NCT04616248

Conditions: Adenocarcinoma, Anatomic Stage IV Breast Cancer AJCC v8, Basal Cell Carcinoma, +44 more
Locations: Los Angeles General Medical Center Los Angeles, California, United States

USC/Norris Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Tumor Virus Infections

Tumor Virus Infections trial results

Related conditions